These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30877497)

  • 1. Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium.
    Lopez-Aguiar AG; Ethun CG; Pawlik TM; Tran T; Poultsides GA; Isom CA; Idrees K; Krasnick BA; Fields RC; Salem A; Weber SM; Martin RCG; Scoggins CR; Shen P; Mogal HD; Beal EW; Schmidt C; Shenoy R; Hatzaras I; Maithel SK
    Ann Surg Oncol; 2019 Jun; 26(6):1814-1823. PubMed ID: 30877497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of perioperative transfusion with survival and recurrence after resection of gallbladder cancer: A 10-institution study from the US Extrahepatic Biliary Malignancy Consortium.
    Lopez-Aguiar AG; Ethun CG; McInnis MR; Pawlik TM; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick BA; Weber SM; Salem A; Martin RCG; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal EW; Hatzaras I; Shenoy R; Cardona K; Maithel SK
    J Surg Oncol; 2018 Jun; 117(8):1638-1647. PubMed ID: 29761515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic blood transfusion does not affect outcome after curative resection for advanced cholangiocarcinoma.
    Müller SA; Mehrabi A; Rahbari NN; Warschkow R; Elbers H; Leowardi C; Fonouni H; Tarantino I; Schemmer P; Schmied BM; Büchler MW
    Ann Surg Oncol; 2014 Jan; 21(1):155-64. PubMed ID: 23982253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Surgical Margin Status on Survival and Recurrence After Pancreaticoduodenectomy for Distal Cholangiocarcinoma: Is Microscopic Residual Tumor (R1) Associated with Higher Rates of Local Recurrence?
    Umino R; Nara S; Mizui T; Takamoto T; Ban D; Esaki M; Hiraoka N; Shimada K
    Ann Surg Oncol; 2024 Aug; 31(8):4910-4921. PubMed ID: 38679686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium.
    Ethun CG; Lopez-Aguiar AG; Pawlik TM; Poultsides G; Idrees K; Fields RC; Weber SM; Cho C; Martin RC; Scoggins CR; Shen P; Schmidt C; Hatzaras I; Bentrem D; Ahmad S; Abbott D; Kim HJ; Merchant N; Staley CA; Kooby DA; Maithel SK
    J Am Coll Surg; 2017 Apr; 224(4):406-413. PubMed ID: 28017812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Perioperative Transfusion on Recurrence and Survival after Gastric Cancer Resection: A 7-Institution Analysis of 765 Patients from the US Gastric Cancer Collaborative.
    Squires MH; Kooby DA; Poultsides GA; Weber SM; Bloomston M; Fields RC; Pawlik TM; Votanopoulos KI; Schmidt CR; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Levine EA; Jin LX; Cho CS; Winslow ER; Russell MC; Staley CA; Maithel SK
    J Am Coll Surg; 2015 Sep; 221(3):767-77. PubMed ID: 26228017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhou PY; Tang Z; Liu WR; Tian MX; Jin L; Jiang XF; Wang H; Tao CY; Ding ZB; Peng YF; Qiu SJ; Dai Z; Zhou J; Fan J; Shi YH
    BMC Cancer; 2017 Nov; 17(1):762. PubMed ID: 29137600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
    Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
    Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal for a new T-stage classification system for distal cholangiocarcinoma: a 10-institution study from the U.S. Extrahepatic Biliary Malignancy Consortium.
    Postlewait LM; Ethun CG; Le N; Pawlik TM; Buettner S; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RCG; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Vitiello G; Cardona K; Maithel SK
    HPB (Oxford); 2016 Oct; 18(10):793-799. PubMed ID: 27506989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma.
    Dekker AM; Wiggers JK; Coelen RJ; van Golen RF; Besselink MG; Busch OR; Verheij J; Hollmann MW; van Gulik TM
    HPB (Oxford); 2016 Mar; 18(3):262-70. PubMed ID: 27017166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatoduodenectomy with portal vein resection for distal cholangiocarcinoma.
    Maeta T; Ebata T; Hayashi E; Kawahara T; Mizuno S; Matsumoto N; Ohta S; Nagino M;
    Br J Surg; 2017 Oct; 104(11):1549-1557. PubMed ID: 28782798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group.
    Poorman CE; Postlewait LM; Ethun CG; Tran TB; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Staley CA; Poultsides GA; Maithel SK
    Am Surg; 2017 Jul; 83(7):761-768. PubMed ID: 28738949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium.
    Krasnick BA; Jin LX; Davidson JT; Sanford DE; Ethun CG; Pawlik TM; Poultsides GA; Tran T; Idrees K; Hawkins WG; Chapman WC; Doyle MBM; Weber SM; Strasberg SM; Salem A; Martin RCG; Isom CA; Scoggins C; Schmidt CR; Shen P; Beal E; Hatzaras I; Shenoy R; Maithel SK; Fields RC
    J Surg Oncol; 2018 Mar; 117(3):363-371. PubMed ID: 29284072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASO Author Reflections: Association of Perioperative Red Blood Cell Transfusion with Increased Disease Recurrence and Worse Survival After Resection of Distal Cholangiocarcinoma.
    Lopez-Aguiar AG; Maithel SK
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):654-655. PubMed ID: 31286311
    [No Abstract]   [Full Text] [Related]  

  • 17. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
    Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
    Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study.
    Strijker M; Belkouz A; van der Geest LG; van Gulik TM; van Hooft JE; de Meijer VE; Haj Mohammad N; de Reuver PR; Verheij J; de Vos-Geelen J; Wilmink JW; Groot Koerkamp B; Klümpen HJ; Besselink MG;
    Acta Oncol; 2019 Jul; 58(7):1048-1055. PubMed ID: 30907207
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study.
    Shen WF; Zhong W; Liu Q; Sui CJ; Huang YQ; Yang JM
    World J Surg; 2011 Sep; 35(9):2083-91. PubMed ID: 21698503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant concurrent chemoradiation therapy in patients with microscopic residual tumor after curative resection for extrahepatic cholangiocarcinoma.
    Lee J; Kang SH; Noh OK; Chun M; Oh YT; Kim BW; Kim SW
    Clin Transl Oncol; 2018 Aug; 20(8):1011-1017. PubMed ID: 29256155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.